Jiangzhong Pharmaceuticals indirect controlling shareholder or change to China Resources Pharmaceutical Group

Pharmaceutical Network May 17th, May 15th evening, Jiangzhong Pharmaceuticals issued a notice that the company's actual controller, Jiangxi Province SASAC is in talks with China Resources Pharmaceutical Group Co., Ltd(hereinafter referred to as "China Resources Pharmaceutical Group") to discuss strategic restructuring of the company's controlling shareholder Jiangxi Jiangzhong Pharmaceutical (Group) Co., Ltd(hereinafter referred to as "Jiangzhong Group"), the company's indirect controlling shareholder may be changed to China Resources Pharmaceutical Groupit is reported that Jiangzhong Pharmaceutical signed off on May 2 because the actual controller of Jiangxi Province's SASAC planned major matters related to the controlling shareholder Jiangzhong Group, which may involve changes in controlJiangzhong Pharmaceutical sonatdown said that at present, Jiangxi Province SASAC is in talks with China ResourcesGroup strategic restructuring Jiangzhong Group matters, the relevant program has not yet been finalized, pending the above-mentioned matters signed a formal agreement, and after the approval of the implementation of the completion, the actual controller of the company may change, the company's indirect controlling shareholders may be changed to China Resources Pharmaceutical GroupOn the same evening of, Jiangzhong Pharmaceuticals announced that it was planning to acquire a controlling stake in China Resources Pharmaceutical Group Co., Ltd., a controlling stake in Jiangxi Pharmaceutical Co., Ltd., jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd., and Jiangxi Nanchang Jisheng Pharmaceutical Co., LtdThe asset acquisition is expected to reach theof a major asset restructuring, and the company's shares will continue to be suspended from May 16financial data show that jiangzhong Pharmaceuticals achieved net profit attributable to about 116 million yuan in the first quarter of 2018, up 6.25 percent year-on-year.